Results 31 to 40 of about 6,633 (220)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats

open access: yesParasites & Vectors, 2018
Background The efficacy of the fixed combination of fluralaner plus moxidectin for the treatment of Otodectes cynotis infestations was evaluated in cats after topical application. Methods Sixteen cats experimentally infested with O.
Janina Taenzler   +3 more
doaj   +1 more source

Effect of Moxidectin on Bed Bug Feeding, Development, Fecundity, and Survivorship

open access: yesInsects, 2017
The common bed bug, Cimex lectularius L. (Hemiptera: Cimicidae), is a blood-feeding ectoparasite which experienced world-wide resurgence during recent decades.
Chen Zha   +2 more
doaj   +1 more source

Anthelmintic resistance in ovine gastrointestinal nematodes in inland southern Queensland [PDF]

open access: yes, 2014
Objective To establish the prevalence of anthelmintic resistance in ovine gastrointestinal nematodes in southern Queensland. Design An observational parasitological study using the faecal egg count reduction test. Methods Sheep farms (n = 20) enrolled in
Ehrlich, W. K.   +2 more
core   +2 more sources

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats

open access: yesParasites & Vectors, 2018
Background Fluralaner provides efficacy against feline ectoparasites following topical administration. Moxidectin is routinely used to treat gastrointestinal nematode infections and prevent heartworm disease caused by Dirofilaria immitis. Praziquantel is
Feli M. Walther   +2 more
doaj   +1 more source

Clinical, laboratory and pathological findings in dogs experimentally infected with Angiostrongylus vasorum [PDF]

open access: yes, 2010
The aim of this comparative study was to investigate the development of clinical signs and accompanying haematological, coproscopic and pathological findings as a basis for the monitoring of health condition of Angiostrongylus vasorum infected dogs.
A Martínez-Moreno   +53 more
core   +1 more source

Clinical experience with the use and efficacy evaluation of new Insacar Total C Plus for dogs and Insacar Total K Plus for cats

open access: yesРоссийский паразитологический журнал, 2023
The purpose of the research is to study the efficacy of new multicomponent drugs for dogs and cats against arachnoentomosis and helminthosis.Materials and methods. The efficacy of new four-component Insacar Total C Plus Drops for Dogs and Insacar Total K
N. V. Makhvatova
doaj   +1 more source

How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control [PDF]

open access: yes, 2017
Background: Great strides have been made toward onchocerciasis elimination by mass drug administration (MDA) of ivermectin. Focusing on MDA-eligible areas, we investigated where the elimination goal can be achieved by 2025 by continuation of current ...
Afework H Tekle   +59 more
core   +5 more sources

The efficacy of antiparasitic drug in the form of spray based on Flumethrin, Moxidectin and Pyriproxyfen against canine acarosis

open access: yesРоссийский паразитологический журнал, 2023
The purpose of the research is to study the efficacy of the drug in the form of spray based on Fipronil, Moxidectin and Pyriproxyfen against canine acarosis.Materials and methods.
M. V. Arisov, S. B. Devyatyarova
doaj   +1 more source

Parasite management practices used by owners of Australian Pony Club horses and the factors influencing their decision‐making processes

open access: yesAustralian Veterinary Journal, EarlyView.
There is a lack of information on horse parasite management practices currently used by individual horse owners in Australia. A voluntary, anonymous online survey was developed for and distributed by Pony Club Australia to its members seeking information on horse population; housing; paddock, manure and parasite management; and owner attitudes.
W Nixon, P Buckley, R Butler
wiley   +1 more source

Home - About - Disclaimer - Privacy